Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation. (2020)
Attributed to:
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjdrc-2020-001238
PubMed Identifier: 32448787
Publication URI: http://europepmc.org/abstract/MED/32448787
Type: Journal Article/Review
Volume: 8
Parent Publication: BMJ open diabetes research & care
Issue: 1
ISSN: 2052-4897